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Murine T cells respond to at least three different types of antigens : (a) H-2
alloantigens, (b) conventional antigens seen in association with selfH-2 determi-
nants (self + X), and (c) minor lymphocyte-stimulating (Mls) determinants . The
fact that individual T cell clones can respond to three diverse types of antigens
raises the question whether recognition of these antigens involves one, or more
than one, type of T cell receptor (TcR) molecule . With the availability of
monoclonal antibodies (mAb) specific for allotypic determinants of the TcR a-,Q
heterodimer, e.g., KJ16 (1) and F23.1 (2), it has been possible to examine
whether such antibodies can inhibit the response of dual-reactive T cell clones,
i.e ., clones reactive with more than one of the above classes of antigens . The
invariable finding has been that anti-TcR antibodies, including anticlonotype
antibodies, are able to inhibit responsiveness of dual-reactive clones and hybri-
domas to both ligands (1, 3-6) . These data have been interpreted as providing
strong support for the view that T cell specificity for all three classes of antigens
is controlled by a single set ofTcR molecules .
We show here that KJ16 and F23 .1 mAb each inhibited the responses of a
triple-reactive T cell clone to all three classes of antigens . Significantly, however,
the anti-TcR mAb also inhibited the response of the clone to IL-2, a ligand that
is not recognized by the TcR . These data suggest that the blocking effects of
anti-TcR antibodies must be interpreted with considerable caution .
Materials and Methods
Mice. B10 .P, B10 .S, and DLLP mice were obtained from the Scripps Clinic and
Research Foundation breeding colony. All other mice were obtained from The Jackson
Laboratories, Bar Harbor, ME .
Preparation of Clones.
￿
B10.D2 (H-2d, Mls") mice were first immunized with F'YG in
vivo ; lymph node T cells from these mice were then stimulated in vitro with allogeneic
B10T (H-2v, Mls') spleen cells . This line was restimulated at 2-wk intervals, first with fowl
y globulin (FyG) plus irradiated syngeneic spleen cells as a source of antigen presenting
cells (APC) and then with F23 .1 antibody in the presence of syngeneic APC . The line was
cloned in the presence of Mls-disparate DBA/2 (H-2d, Mls,A) irradiated spleen cells .
Cell Culture.
￿
T cell lines and clones were maintained in vitro by culturing 2-3 x 105
cells with 4.0 x 10' irradiated (3,000 rad) spleen stimulator cells in 10 ml ofRPM1 1640
medium containing 10% FCS (Hyclone, Logan, UT), 5% NCTC 109 (Whittaker M . A .
Bioproducts, Walkersville, MD), glutamine, 2-ME, and antibiotics . When appropriate,
100 Ag/ml FyG was added . Viable cells were restimulated at 14-d intervals . Cloning was
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TABLE I
Specificity of Triple-reactive T Cell Clone K3.2. Lc9
Results
* Stimulators were anti-Thy-1 + C'-treated spleen cells ; 1,500 rad .
x Proliferative response of 1 .5 x 10' K3 .2 . 1 .c9 cells measured on day 3 . Mean cpm
of triplicate cultures ; SD were usually between 10-20% of mean .
o Positive responses are underlined.
carried out at limiting dilution (^-0.3 cells/well) 48 h after the last restimulation in 96-
well round-bottom microtiter plates with irradiated spleen cells. Rat Con A culture
supernatant (SN) was added as a source of IL-2 . The clone K3 .2 . 1 .c9 has been subcloned
repeatedly over the last two years ; all subclones have always shown the same specificity as
the parent in proliferation assays.
For proliferation assays, 2 x 104 cloned T cells were cultured in round-bottom
microtiter wells with the indicated number of irradiated (1,500 rad) anti-Thy-1 + C'-
treated spleen cells in 200 ul culture medium . Responses were measured by pulsing with
[sH]thymidine ([ sH]TdR) 16-18 h before harvesting. In inhibition assays, the indicated
concentration of antibody was added on day 0 and remained in the culture for the
duration of the experiment .
Antibodies Used .
￿
KJ16.133 hybridoma cells were kindly provided by P . Marrack and
J . Kappler, National Jewish Hospital, Denver, CO (1) . The F(ab') 2 fragments were
prepared from ascites using pepsin as described by Parham (7), and were purified using
an ACA 44 column . The Fab (papain) fragments were prepared according to the
procedure of Kaye (3) and then purified on a DEAE column . The samples were analyzed
on a 7% SDS polyacrylamide gel and showed no contamination with uncleaved antibody .
The F23.1 ascites fluid, as well as the F(ab') 2 fragments of this antibody were kindly
provided by Drs . U . Staerz andM . Bevan, Scripps Clinic and Research Foundation .
IL-2.
￿
Recombinant human IL-2 (rIL-2) was kindly provided by Cetus Corp ., Emery-
ville, CA .
As described in Materials and Methods, we have isolated a 1310.D2 (H-2d)
clone, K3.2 . 1 .c9, with specificity for (a) F-yG + H-2d , (b) allo-H-2p ,band (c) Mlsa ,d
determinants (Table 1) . This clone is L3T4+ , Lyt-2- , F23 .1 + , and KJ16+ . Exper-
iments comparing the degree of inhibition seen with limiting concentrations of
anti-L3T4 mAb and limiting numbers ofAPC suggested that the relative avidity
of the clone for the three ligands was not demonstrably different (data not
Stimulators* H-2/Mls
Proliferative response*
(['H]TdR uptake [cpm x 10'])
Exp . I Exp. 11 Exp . III
B10.132 d b 4 .5 0 .2 0 .4
B1 O.D2 + FyG d b 29.01 NT 18 .5
BIO.BR k b 0 .5 0 .1 0 .3
BI OT p b 70 .5 24 .0 23 .0
C57BL/10 66 NT NT 13 .2
BIO.S s b NT NT 0 .4
B10.PL u b NT 1 .3 NT
CBA/Ca k b NT 0 .3 0 .7
C3H/Hej k c NT 0 .1 0 .5
BALB/C d b NT 0 .1 NT
C57BR k b NT 0 .2 0 .4
CBA/J k d 63 .5 57 .5 20 .6
AKR/J k a 57 .5 40 .7 11 .5
SM/J v a 136 .3 17 .8 NT
DBA/2 d a 73 .7 16 .3 7 .9
PL/1 u x NT 6 .8 19 .1
D1 .LP b a 28 .7 NT 7 .5586 WEBB AND SPRENT
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FIGURE 1 .
￿
Anti-TcR inhibition of the proliferative response of the T cell clone, K3.2 . 1 .c9,
to : FyG in the presence of syngeneic B10.D2 (H-2d Mls b ) spleen ; Mls, CBA/J (H-2k' Mls' .d)
spleen ; allo-H-2P, B10 .P, (H-2P, Mlsb) spleen ; syngeneic B10.D2 spleen; and B10.BR (H-2
k,
Mlsb) spleen . All spleen cell preparations were anti-Thy-1 + complement-treated . The re-
sponses were measured in the absence of added antibody (0) or in the presence of KJ16 (0) or
F23 .1 (o) mAb.
TABLE 11
F(ab')2 andFab Fragments ofAntireceptor Antibodies Inhibit Proliferative
Responses ofK3.2.1.c9
* All antibodies were used at concentrations that did not show nonspecific inhibition of the KJ16-/F23 .1- clone
K3 . 1 .0 . The percentages are of the following stock antibody preparations; KJ16, 1% of culture supernatant ;
KJ16 F(ab') 2 , 4 .0 jig/ml ; F23.1, 1 :10' dilution of ascites; F23 .1 F(ab')Q , 3 .6 rig/ml . All responses were titrated
and optimal dilution was chosen for each antibody .
$ See footnotes to Table 1 .
shown)! Another clone, K3 . Lc7, was used as a specificity control ; this clone has
the same triple-specificity as K3.2 . 1 .c9 but is F23.1- , KJ16- .
Inhibition with Anti-TcR mAbs .
￿
As shown in Fig . 1, the day 4 response of the
K3.2 . Lc9 clone to each of the three antigens, FyG, Mls (CBA/J), and allo-H-2
(B10T), was markedly reduced by adding KJ16 or F23.1 mAb to the cultures .
By contrast at earlier time points, e .g ., day2, theresponses were either unaffected
or slightly enhanced, especially in the case of responses to F'yG and allo-H-2P.
Table II illustrates that F(ab')2 fragments, as well as Fab fragments have similar
effects as the whole molecule . Anti-Mls"d responses were often depressed on day
2 by anti-TcR antibodies, but definite enhancement (followed by inhibition on
fy0/B10.D2 CBAIJ MY
r
1 ' 1 810.0 B10.BR
0 No antibody
0 XJ16.133
o f13.1
Exp . Anti-TcR anti-
body*
['H]TdR
B10M
uptake (cpm
CBA/J
x 10- ') with stimulators on
B10.1'
day 2 or
B10 .
4$
D2/FyG
2 4 2 4 2 4 2 4
1 0 0.2 1 .9 8 .9 12 .1 12 .0 37 .6 11.0 91 .1
KJ16 - - 3 .3 0 .3 9 .9 8 .3 17.9 13.2
KJ16 F(ab')2 - - 1 .5 0 .2 15 .4 10 .3 16.0 14.0
F23 .1 9.9 0 .4 7 .5 1 .2 16 .4 0 .6 12.1 0 .5
F23 .1 F(ab')2 0.4 0 .1 1 .6 0 .3 15 .9 4 .9 19.7 6 .1
11 0 0.5 0 .2 8 .5 20 .4 11 .7 16 .5 13.0 38.2
KJ 16 - - 0 .6 0 .6 11 .7 1 .8 19.1 1.2
KJ16 Fab - - 16 .1 2 .5 16 .1 3 .6 19.2 6.9WEBB AND SPRENT
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FIGURE 2 .
￿
Inhibition of IL-2-induced proliferation with F23.1 mAb. K3.2.I.c9 (F23 . I')and
K3 .1 .c7 (F23 .1 -) clones were incubated with 10 U/ml rIL-2 either with (") or without (O)
F23.1 mAb .
day 4) was seen in some experiments, e.g., with KJ 16 Fab fragments (Table II,
bottom) .
Intact F23.1 mAb is mitogenic for the K3 .2 . 1 .c9 clone (Fig. 1) ; stimulation of
the clone with intact F23.1 mAb requires feeder cells (spleen cells), but the H-2
haplotype of the feeders is irrelevant . KJ16 antibodies, on the other hand, have
no demonstrable stimulatory effect on the clone.
Capacity of Anti-TcR mAb to Inhibit IL-2-induced Proliferation.
￿
The fact that
the inhibitory effects of the anti-TcR mAbs on the response of the K3 .2.1 .c9
clone were often preceeded by enhancement suggested that the antibodies were
not acting simply by blockingT cell recognition of thethreeantigens in question .
If other mechanisms were involved, anti-TcR mAb might be expected to alter
the response of the clone to a stimulus not involving TcR, e.g., a response to IL-
2 . In this respect, experiments with the F23.1 mAb showed marked inhibition
of the response of the K3.2.I .c9 clone to rIL-2 (Fig . 2) ; the kinetics of inhibition
were very similar to that seen above with antigen, i.e ., inhibition on days 3-5
but not on day 2. Little or no inhibition was observed in control studies with an
F23 .1 - clone, K3.1 .c7. KJ16mAb and Fab fragments also inhibited the response
to IL-2, although the effect was sometimes less marked than with F23.1 mAb
(data not shown) .
Discussion
Although it is generally accepted that reactivity to self + X and allo-H-2
determinants reflects crossreactive recognition by a single set of TcR a-,8 heter-
odimers (1, 8), we have previously reported data suggesting that Mls determinants
might be recognized by a different cell surface molecule (9) . The strongest
evidence against this notion has been the demonstration that Mls-reactivity can
be inhibited by typical anti-TcR mAb (1, 4-6) . In confirmation of this finding,
we show here that all three reactivities displayed by a T cell clone, including Mls
reactivity, can be blocked by anti-TcR mAb. Surprisingly, however, anti-TcR
mAb also inhibited the response of the clone to IL-2, implying that at least in
certain situations, anti-TcR mAb can cause nonspecific downregulation of T588
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cells . The capacity of anti-TcR mAb to inhibit Mls-reactivity thus provides no
evidence either for or against the notion that Mls determinants are recognized
by separate molecules . Downregulation of T cells has also been observed with
antibodies to T accessory molecules (10-12); there is also a report that the
response ofa T8' suppressorT cell clone to IL 2 can be inhibited by anticlono-
typic mAb (13) .
In attempting to explain the paradoxical enhancing/inhibiting effects of anti-
TcR, it should be noted that intact F23 .1 mAb is clearly mitogenic for F23 .1 +
T cells (Fig. 1) ; the response peaked early, i .e ., on day 2 or 3, and then declined
rapidly . Interestingly, very similar kinetics were observed when the clone was
cultured with F23 .1 mAb in the presence of antigen (Fig . 1, panels 1-3),
suggesting that the transient response of the clone to F23 .1 mAb preempted the
response to antigen. Demonstrable mitogenicity was not usually seen with F(ab')2
fragments or with KJ16 antibodies (Table II) . It is possible, however, that these
latter preparations were covertly mitogenic ; the cells received a signal from the
antibodies that was insufficient by itself to promote DNA synthesis but was
sufficient to prime the cells for contact with antigen . In favor of this idea, we
have recently found that prior overnight incubation of the clone with KJ 16 mAb
(without antigen) followed by washing leads to an accelerated response of the
clone to each ofthethreeantigens (datanotshown) .Whyanti-TcR causes latedown-
regulation of the clone, e.g ., to IL-2, is unclear . One possibility is that downre-
gulation reflects excessive signalling through theTcR; in this respect it is accepted
that high concentrations of antigen are often inhibitory forT cells (14) . Another
possibility is that antibody binding to the TcR prevents theT cells from receiving
a protective signal from the APC, i.e ., a signal that counteracts downregulation .
Although the mechanism by which anti-TcR mAb downregulate T cells is still
unclear, themain conclusion to bedrawn from the present studies is that blocking
effects noted with anti-TcR mAb do not necessarily reflect simple occlusion of
the binding sites on the TcR molecule .
Summary
We have derived aT cell clone that recognizes and responds to three different
types of antigen : self +X (fowl gamma globulin + H-2d), allo-H-2P.b , and minor
lymphocyte-stimulating (Mlsa,d ) determinants . Anti-TcR mAb and their F(ab')2
and Fab fragments were tested for their capacity to block the response of this
clone . When responses were assayed on day 4 or later, addition ofKJ16 or F23.1
mAb caused a marked inhibition of the response to each of the three antigens
recognized by the clone . Responses measured at earlier time points however
were unaffected or enhanced . This finding suggested that the inhibitory effects
of anti-TcR mAb that followed the phase of enhancement might have reflected
downregulation of the cells rather than simple blockade of TcR. In support of
this possibility it was found that addition of anti-TcR mAb caused marked
inhibition of the response of the clone to IL-2, i.e ., a response that is not known
to involve the TcR.
We wish to thank Annette Okamoto for excellent technical assistance .
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